Sodium Glucose Co-Transporter 2 Inhibitors Clinical Trials

7 clinical trials for Sodium Glucose Co-Transporter 2 Inhibitors across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• meChANisms and sAfety of SGLT2 Inhibition in peRitoneal dialYsis — RECRUITING · PHASE3
• Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Adolescents With Early Stages of Chronic Kidney Disease — RECRUITING · PHASE4
• Dapagliflozin Delays the Loss of Renal Function in Peritoneal Dialysis Patients — RECRUITING · NA
• SGLT2i Effect on PTDM Development and Kidney Allograft Function in Non-diabetic Kidney Transplant Recipients: A Randomized, Doubleblind, Placebo Controlled, National Multicenter Trial — NOT_YET_RECRUITING · PHASE2
• Sodium Glucose Co-Transporter 2 Inhibitors on Estimated Glomerular Filtration Rate in Diabetic Versus Non-Diabetic Chronic Kidney Disease Patients — COMPLETED
• Dapagliflozin to Prevent Atrial Fibrillation Recurrence After Transcatheter Pulmonary Venous Isolation. — OTHER · PHASE1
• Dapagliflozin to Prevent the Incidence of Contrast Induced Nephropathy After Heart Catheterization and Percutaneous Coronary Intervention — OTHER · PHASE1

Refine this search